A reduction in GLP1 dose or a pause in dose escalation to prioritize lean body mass preservation
The nooms microdose GLP-1 program noticed this issue and launched GLP-1's better and sustainable version to rank at the microdose level.
Additionally, a phase 2 trial of patients with type 2 diabetes has shown tirzepatide improves cardiovascular biomarkers [59, 60]
Apart from those with a history of thyroid cancer, individuals with severe gastrointestinal diseases, such as gastroparesis, should also avoid this medication
Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: The SURPASS-5 randomized clinical trial
Definition Retatrutide: A 39-amino-acid synthetic peptide that activates the GIP, GLP-1, and glucagon receptors simultaneously